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Spectrum Health, Grand Rapids, MI, USA, 2 University Hospitals Case Medical Center, Cleveland, OH, USA, 3 Bend Memorial Clinic, Bend, OR, USA, 4 Central Carolina Surgery, Greensboro, NC, USA, 5 KJT Group LLC, Honeoye Falls, NY, USA, 6 GlaxoSmithKline, Research Triangle Park, NC, USA, 7 Adolor Corporation, Exton, PA, USA OBJECTIVES: Shorter length of stay (LOS) has been associated with perioperative bowel resection (BR) care pathway use for elective procedures, yet little is known about how characteristics of hospitals with such pathways may affect LOS. This study examined differences between hospitals with and without elective BR pathways and surgeons in these settings. METHODS: A cross-sectional, web-based survey was conducted among general and colorectal surgeons regarding their last elective BR patient. To qualify, surgeons had to be licensed to practice in US, in practice 2-30 years, and conduct at least 1 BR/typical month. Logistic regression was conducted to determine whether care pathway presence in hospitals was associated with a shorter LOS, defined as <4 days. Controlling variables included: surgeon specialty, years in practice, age, ethnicity, gender, BR surgery volume. Hospital variables included: practice type, location, region, number of beds, presence of electronic medical record. Statistical significance was defined as p < 0.10. RESULTS: Data were analyzed from 91 general and 112 colorectal surgeons from their most recent laparoscopic BR. Thirty-five percent practice in a hospital with elective BR perioperative care pathways which contained accelerated GI recovery components. The multivariate logistic regression showed that hospitals with elective BR care pathways were more likely to have a shorter LOS (<4 days) (Odds Ratio: 2.40, p < 0.01). A shorter LOS (<4 days) was also associated with fewer years in practice (2 to 15 years, p < 0.05) and working in a practice that is equally hospital and office/clinic based (p < 0.01). CONCLUSIONS: This analysis provides evidence that, after controlling for numerous surgeon and hospital characteristics, the presence of care pathways at the hospital level is associated with shorter LOS for laparoscopic BR patients. While self-reported, these data provide a good first step at defining additional research to determine the role of care pathways on patient outcomes after BR. We examined the effect of duration of overlap for patients who bridged from low weight molecular heparin to warfarin for patients who underwent total hip and total knee replacement surgery. METHODS: A retrospective study (January 1, 2005 to December 31, 2007) was conducted using a subset of the MarketScan Hospital Drug Database and its linked outpatient files from the Market Scan Commercial and Medicare Supplemental database. Patients' demographic, clinical and provider characteristics were compared using Chi-square testing and standardized differences. Riskadjusted event rates were estimated using the Poisson regression model. RESULTS: The linked database is comprised of 2280 enrollees, of whom 1769 met the eligibility criteria: 490 underwent hip replacement surgery and 1279 underwent knee replacement surgery. Fifteen percent of these patients received combination therapy, including 75 patients in the hip replacement surgery group and 189 in the knee replacement surgery group. Each day with overlap decreased the risk-adjusted incidence rate of venous thromboembolism (VTE) 0.857 times (CI: 0.7284-0.957) for patients who underwent major orthopedic surgery. The rates were 0.957 times (CI:0.904-0.987) lower for major bleeding and 0.895 times (CI:0.737-0.967) lower for minor bleeding for each day of overlap. CONCLUSIONS: Duration of bridging therapy varies widely and does not appear to be consistent with published guidelines. (1) To analyze how overall and condition-specific preventable hospitalization (PH) rates changed over time (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , and 2) To analyze how PH rates varied across small market areas and whether the spatial distribution patterns changed over time. METHODS: The study uses hospital discharge data from the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID) for the states-AZ, CA,OR,WA, MA, MD, NJ, and NY for 1995 and 2005. The unit of analysis is the Primary Care Service Area (PCSA). Unadjusted and age-adjusted PH rates were computed by PCSA for overall and condition-specific trends. Coefficient of variation (CV) was used as an indicator of small area variation. RESULTS: The 1995-2005 trends reveal that elderly PH rates per 1000 total discharges were higher for eastern states than western states for the elderly, while the magnitude of variation across PCSAs was lower among eastern states than in western states. Adult PH rates remained steady over time as a whole in eight states, with rates consistently lower than the elderly PH rates. The combined results for all eight states show that, small area variation declined between 1995 and 2005 for both elderly (0.25 to 0.20) and adults (0.33 to 0.30), indicating a greater decline in variation among the elderly compared to adults. Elderly hospitalization rates were highest for CHF, bacterial pneumonia, kidney/UTI and angina. Adult hospitalization rates were the highest for bacterial pneumonia, asthma, CHF and cellulitis. CONCLUSIONS: The study shows that in the last decade PH rates declined in eight states for both elderly and adults. Along with the declining trends, there was also a decline in variation across primary care markets for both adults and the elderly. The reductions were greater in the elderly than among the adults in both PH rates as well as small area variations in these rates.
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Pizzi LT, Lee EH, Thompson E, Berman B Thomas Jefferson University, Philadelphia, PA, USA OBJECTIVES: US efforts to improve the quality of medication therapy are expanding through inclusion of medication measures in the CMS Physician Quality Reporting Initiative (PQRI), NCQA Health Plan Employer Data and Information Set (HEDIS), and testing of pharmacy measures by the Pharmacy Quality Alliance (PQA). Our objectives were to 1) review outpatient physician and pharmacy measures for 3 major chronic diseases; 2) examine conceptual overlap between the measures; and 3) propose a framework for integrating the measures to foster a team approach to quality. METHODS: Physician measures for diabetes, dyslipidemia, and asthma were obtained
